Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

US Food and Drug Administration Perspectives on Clinical Mass Spectrometry.

Lathrop JT, Jeffery DA, Shea YR, Scholl PF, Chan MM.

Clin Chem. 2016 Jan;62(1):41-7. doi: 10.1373/clinchem.2015.244731. Epub 2015 Nov 9. Review.

2.

Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis.

Maiga M, Siddiqui S, Diallo S, Diarra B, Traoré B, Shea YR, Zelazny AM, Dembele BP, Goita D, Kassambara H, Hammond AS, Polis MA, Tounkara A.

PLoS One. 2012;7(5):e36902. doi: 10.1371/journal.pone.0036902. Epub 2012 May 16.

3.

GI involvement in disseminated Mycobacterium genavense: endoscopy and histology.

Arora M, Uzel G, Shea YR, Kleiner DE, Holland SM, Heller T.

Gastrointest Endosc. 2011 Sep;74(3):688-90. doi: 10.1016/j.gie.2011.04.021. Epub 2011 Jul 26. No abstract available.

4.

Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.

De Ravin SS, Challipalli M, Anderson V, Shea YR, Marciano B, Hilligoss D, Marquesen M, Decastro R, Liu YC, Sutton DA, Wickes BL, Kammeyer PL, Sigler L, Sullivan K, Kang EM, Malech HL, Holland SM, Zelazny AM.

Clin Infect Dis. 2011 Mar 15;52(6):e136-43. doi: 10.1093/cid/ciq250.

5.

Sixty-year-old man with slowly expanding nodular plaque on the thigh.

Wu PA, Turner ML, Cowen EW, Wilson E, Shea YR, Jancel T, Freeman AF.

J Am Acad Dermatol. 2010 Dec;63(6):1083-7. doi: 10.1016/j.jaad.2010.06.029. No abstract available.

6.

Death by edible mushroom: first report of Volvariella volvacea as an etiologic agent of invasive disease in a patient following double umbilical cord blood transplantation.

Salit RB, Shea YR, Gea-Banacloche J, Fahle GA, Abu-Asab M, Sugui JA, Carpenter AE, Quezado MM, Bishop MR, Kwon-Chung KJ.

J Clin Microbiol. 2010 Nov;48(11):4329-32. doi: 10.1128/JCM.01222-10. Epub 2010 Sep 8.

7.

Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species.

Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR.

J Clin Microbiol. 2010 Oct;48(10):3482-6. doi: 10.1128/JCM.00687-09. Epub 2010 Jul 28.

8.

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN.

Am J Respir Crit Care Med. 2010 Oct 1;182(7):970-6. doi: 10.1164/rccm.201002-0310OC. Epub 2010 Jun 10.

9.

Pharmacokinetics of liposomal amphotericin B in pleural fluid.

Moriyama B, Torabi-Parizi P, Pratt AK, Henning SA, Pennick G, Shea YR, Roy Chowdhuri S, Rinaldi MG, Barrett AJ, Walsh TJ.

Antimicrob Agents Chemother. 2010 Apr;54(4):1633-5. doi: 10.1128/AAC.01438-09. Epub 2010 Jan 19.

10.

Fusarium proliferatum soft tissue infection at the site of a puncture by a plant: recovery, isolation, and direct molecular identification.

Palmore TN, Shea YR, Childs RW, Sherry RM, Walsh TJ.

J Clin Microbiol. 2010 Jan;48(1):338-42. doi: 10.1128/JCM.01525-09. Epub 2009 Nov 18.

11.

Neosartorya udagawae (Aspergillus udagawae), an emerging agent of aspergillosis: how different is it from Aspergillus fumigatus?

Sugui JA, Vinh DC, Nardone G, Shea YR, Chang YC, Zelazny AM, Marr KA, Holland SM, Kwon-Chung KJ.

J Clin Microbiol. 2010 Jan;48(1):220-8. doi: 10.1128/JCM.01556-09. Epub 2009 Nov 4.

12.

Chronic invasive aspergillosis caused by Aspergillus viridinutans.

Vinh DC, Shea YR, Jones PA, Freeman AF, Zelazny A, Holland SM.

Emerg Infect Dis. 2009 Aug;15(8):1292-4. doi: 10.3201/eid1508.090251.

13.

Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome.

Melia E, Freeman AF, Shea YR, Hsu AP, Holland SM, Olivier KN.

J Allergy Clin Immunol. 2009 Sep;124(3):617-8. doi: 10.1016/j.jaci.2009.07.007. No abstract available.

14.

Invasive aspergillosis due to Neosartorya udagawae.

Vinh DC, Shea YR, Sugui JA, Parrilla-Castellar ER, Freeman AF, Campbell JW, Pittaluga S, Jones PA, Zelazny A, Kleiner D, Kwon-Chung KJ, Holland SM.

Clin Infect Dis. 2009 Jul 1;49(1):102-11. doi: 10.1086/599345.

15.

Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii.

Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, Conlan S, McNulty S, Brown-Elliott BA, Wallace RJ Jr, Olivier KN, Holland SM, Sampaio EP.

J Clin Microbiol. 2009 Jul;47(7):1985-95. doi: 10.1128/JCM.01688-08. Epub 2009 May 6.

16.

Mucormycosis in chronic granulomatous disease: association with iatrogenic immunosuppression.

Vinh DC, Freeman AF, Shea YR, Malech HL, Abinun M, Weinberg GA, Holland SM.

J Allergy Clin Immunol. 2009 Jun;123(6):1411-3. doi: 10.1016/j.jaci.2009.02.020. Epub 2009 Apr 14. No abstract available.

17.

High sensitivity and specificity of acid-fast microscopy for diagnosis of pulmonary tuberculosis in an African population with a high prevalence of human immunodeficiency virus.

Shea YR, Davis JL, Huang L, Kovacs JA, Masur H, Mulindwa F, Opus S, Chow Y, Murray PR.

J Clin Microbiol. 2009 May;47(5):1553-5. doi: 10.1128/JCM.00348-09. Epub 2009 Mar 18.

18.

"Mycobacterium tilburgii," a newly described, uncultivated opportunistic pathogen.

Palmore TN, Shea YR, Conville PS, Witebsky FG, Anderson VL, Rupp Hodge IP, Holland SM.

J Clin Microbiol. 2009 May;47(5):1585-7. doi: 10.1128/JCM.02385-08. Epub 2009 Mar 4.

19.

Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis.

Davis JL, Huang L, Kovacs JA, Masur H, Murray P, Havlir DV, Worodria WO, Charlebois ED, Srikantiah P, Cattamanchi A, Huber C, Shea YR, Chow Y, Fischer SH.

Clin Infect Dis. 2009 Mar 15;48(6):725-32. doi: 10.1086/597038.

20.

Mycobacterium abscessus and M. avium trigger Toll-like receptor 2 and distinct cytokine response in human cells.

Sampaio EP, Elloumi HZ, Zelazny A, Ding L, Paulson ML, Sher A, Bafica AL, Shea YR, Holland SM.

Am J Respir Cell Mol Biol. 2008 Oct;39(4):431-9. doi: 10.1165/rcmb.2007-0413OC. Epub 2008 Apr 25.

21.

Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species.

Montero CI, Shea YR, Jones PA, Harrington SM, Tooke NE, Witebsky FG, Murray PR.

Eur J Clin Microbiol Infect Dis. 2008 Sep;27(9):821-30. doi: 10.1007/s10096-008-0510-x. Epub 2008 Apr 18.

22.

Emericella quadrilineata as cause of invasive aspergillosis.

Verweij PE, Varga J, Houbraken J, Rijs AJ, Verduynlunel FM, Blijlevens NM, Shea YR, Holland SM, Warris A, Melchers WJ, Samson RA.

Emerg Infect Dis. 2008 Apr;14(4):566-72. doi: 10.3201/eid1404.071157. Review.

23.

Infections caused by Scedosporium spp.

Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, Buchanan W, Milanovich J, Sutton DA, Fothergill A, Rinaldi MG, Shea YR, Zaoutis T, Kottilil S, Walsh TJ.

Clin Microbiol Rev. 2008 Jan;21(1):157-97. doi: 10.1128/CMR.00039-07. Review.

24.

Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.

Siddiqui S, Anderson VL, Hilligoss DM, Abinun M, Kuijpers TW, Masur H, Witebsky FG, Shea YR, Gallin JI, Malech HL, Holland SM.

Clin Infect Dis. 2007 Sep 15;45(6):673-81. Epub 2007 Aug 8.

PMID:
17712749
25.

Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.

Santos PE, Piontelli E, Shea YR, Galluzzo ML, Holland SM, Zelazko ME, Rosenzweig SD.

Med Mycol. 2006 Dec;44(8):749-53.

PMID:
17127632
26.

Relationship between metabolism and biomass of medically important zygomycetes.

Antachopoulos C, Meletiadis J, Roilides E, Sein T, Sutton DA, Wickes BL, Rinaldi MG, Merz WG, Shea YR, Walsh TJ.

Med Mycol. 2006 Aug;44(5):429-38.

PMID:
16882609
27.
28.

Identification of Mycobacterium species by secA1 sequences.

Zelazny AM, Calhoun LB, Li L, Shea YR, Fischer SH.

J Clin Microbiol. 2005 Mar;43(3):1051-8.

29.

Invasive infection with Trichosporon inkin in 2 siblings with chronic granulomatous disease.

Wynne SM, Kwon-Chung KJ, Shea YR, Filie AC, Varma A, Lupo P, Holland SM.

J Allergy Clin Immunol. 2004 Dec;114(6):1418-24.

PMID:
15577847
30.

Regarding "Trichosporon pullulans infection in 2 patients with chronic granulomatous disease".

Holland SM, Shea YR, Kwon-Chung J.

J Allergy Clin Immunol. 2004 Jul;114(1):205-6; author reply 206. No abstract available.

PMID:
15282941
31.

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2.

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.

J Immunother (1991). 2001 Mar;24(2):188-192.

PMID:
11449076
32.

A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2.

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.

J Immunother. 2001 Mar-Apr;24(2):188-92.

PMID:
11265777

Supplemental Content

Support Center